Jack Nathan Medical Corp.
JNH.V
TSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 230.36% | 204.31% | 206.39% | 24.48% | 8.46% |
| Total Depreciation and Amortization | -62.88% | -37.37% | -11.62% | 11.27% | -2.83% |
| Total Amortization of Deferred Charges | -68.18% | -45.30% | -72.86% | -62.01% | -61.54% |
| Total Other Non-Cash Items | -630.39% | -872.21% | -32,094.59% | -217.20% | -227.43% |
| Change in Net Operating Assets | 24.08% | 145.54% | 140.57% | -202.98% | -226.06% |
| Cash from Operations | 38.28% | 34.85% | 1.34% | -52.81% | -93.11% |
| Capital Expenditure | 82.02% | 83.02% | 72.65% | 53.13% | 20.52% |
| Sale of Property, Plant, and Equipment | 39,836.36% | 39,836.36% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 252.28% | 218.51% | 202.82% | 54.95% | 23.92% |
| Total Debt Issued | -76.72% | -96.13% | -93.48% | -55.91% | -75.57% |
| Total Debt Repaid | 69.52% | 51.54% | 35.71% | -2.09% | -3.81% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -115.94% | -115.53% | -55.43% | -45.89% | -24.43% |
| Cash from Financing | -101.74% | -101.70% | -91.74% | -68.41% | -74.44% |
| Foreign Exchange rate Adjustments | -725.14% | -77.12% | 105.76% | 34.63% | 108.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.44% | -201.91% | -148.39% | -229.33% | -198.60% |